SGO Journal Club On-Demand: Advanced Endometrial Cancer—the Next Generation of Treatment

The case: 53yo S/P hysterectomy/BSO/SLND for FIGO grade3 endometrial cancer with extensive LVSI and no myometrial invasion. Further imaging identifies lung nodules biopsied positive for endometrioid adenocarcinoma.  
 
Questions to consider: 
1. What molecular testing should be performed by Pathology on this case?
2. What treatment strategy should we take?
 
Reference Links:
PMID: 37337978
PMID: 29432521
PMID: 36972022
PMID: 36972026
PMID: 37864337
 
 
Panelists:
Dana Chase, MD, FACOG
Associate Professor, Obstetrics & Gynecology, UCLA
 
Tony Karnezis, MD, PhD
Associate Professor, Department of Pathology
UC Davis Medical Center 
 
Todd Tillmanns, MD, FACOG
Gynecologic Oncologist, West Cancer Center & Research Institute
 
Moderators:
Lee-may Chen, MD
Gynecologic Oncologist and Gynecologic Oncology Division Director, UCSF
 
Renata Urban, MD
Gynecologic Oncologist, UW Medical
 
Keywords: journal, journal club, endometrial, endometrial cancer, advanced endometrial cancer

You may also be interested in

Endometrial Cancer Education Module
Resource for APPs new to practicing in gynecologic oncology or who may want a refresher on endometrial cancer considerations.
2025 Masterclass: More than Additive - Multiplying Our IMPACT in Endometrial Cancer Care
This session discusses endometrial cancer care from the role of surgery, radiation, and systemic treatment along with the application and impact of molecular classification in treatment options.
Listen along as panelists discuss management and treatment of advanced endometrial cancer.

Course summary

Course opens: 
02/13/2024
Course expires: 
02/12/2029
Cost:
$0.00
Rating: 
0

Price

Cost:
$0.00
Please login or register to take this course.